Bare Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37K Buy
72
+10
+16% +$583 ﹤0.01% 712
2025
Q4
$3.35K Sell
62
-44
-42% -$2.12K ﹤0.01% 688
2025
Q3
$4.78K Sell
106
-56
-35% -$2.62K ﹤0.01% 564
2025
Q2
$7.5K Buy
162
+153
+1,700% +$7.51K ﹤0.01% 271
2025
Q1
$549 Buy
+9
New +$525 ﹤0.01% 762

Other funds holding BMY

Bare Financial Services's BMY Position: Q1 2026 in Review

Bare Financial Services increased its Bristol-Myers Squibb (BMY) stake by 16% in Q1 2026, buying an estimated $583 and bringing the position to 72 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #712.

Bare Financial Services first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $7.5K in Q2 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bare Financial Services held 72 shares of Bristol-Myers Squibb worth $4.37K as of Q1 2026.
  • Bare Financial Services bought 10 Bristol-Myers Squibb shares in Q1 2026, an estimated $583.
  • Bristol-Myers Squibb made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #712 holding.
  • Bare Financial Services first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • Bare Financial Services's Bristol-Myers Squibb position peaked at $7.5K in Q2 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.